LATANOPROST OPHTHALMIC SOLUTION 0.005%

Glaucoma Agent

Brand names: IYUZEH

Ophthalmic

Mechanism of Action

12.1 Mechanism of Action Latanoprost is a prostaglandin F 2α analogue that is believed to reduce the IOP by increasing the outflow of aqueous humor. Studies in animals and man suggest that the main mechanism of action is increased uveoscleral outflow. Elevated IOP represents a major risk factor for glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss.

Indications

See full prescribing information

Contraindications

• 4 CONTRAINDICATIONS Known hypersensitivity to latanoprost or any other ingredients in this product. Known hypersensitivity to latanoprost or any other ingredients in this product. ( 4 )

FDA Warnings

5 WARNINGS AND PRECAUTIONS Pigmentation : Pigmentation of the iris, periorbital tissue (eyelid) and eyelashes can occur
IYUZEH should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema

Known Side Effects

8 documented side effects by frequency

Drug Not Working

>10%

Fatigue

1-10%

Headache

1-10%

Shortness of Breath

1-10%

Blurred Vision

1-10%

Dizziness

1-10%

Diarrhea

0.1-1%

Nausea

0.1-1%

Community Discussions

No community discussions found for LATANOPROST OPHTHALMIC SOLUTION 0.005% yet.

Compare With

15 available comparisons

Formulations

Dosage Forms

Tablet

Route

Ophthalmic